Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yardena Samuels

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Nature Genetics|September 12, 2006
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53Daniele Bergamaschi, Yardena Samuels, Alexandra Sullivan, et al.
Cell|April 17, 2026
Mapping intratumor heterogeneity across layers for advancing immunotherapyJean-Christophe Marine, Osnat Bartok, Shira Sagie, et al.
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Cancer Research|October 3, 2007
Serial assessment of human tumor burdens in mice by the analysis of circulating DNACarlo Rago, David L Huso, Frank Diehl, et al.
Oncotarget|October 3, 2014
The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapiesDaniel Martin, Martin C Abba, Alfredo A Molinolo, et al.
Pigment Cell & Melanoma Research|September 25, 2019
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanomaAdi Nagler, David W Vredevoogd, Michal Alon, et al.
Nature Genetics|September 1, 2009
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4Todd D Prickett, Neena S Agrawal, Xiaomu Wei, et al.
Cancer Research|December 17, 2008
Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanomaDavid A Solomon, Jung-Sik Kim, Julia C Cronin, et al.
The Journal of Investigative Dermatology|April 18, 2014
Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formationTodd D Prickett, Brad J Zerlanko, Victoria K Hill, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|June 15, 2016
Parkin Somatic Mutations Link Melanoma and Parkinson's DiseaseLotan Levin, Shani Srour, Jared Gartner, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Nature Genetics|September 12, 2006
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53Daniele Bergamaschi, Yardena Samuels, Alexandra Sullivan, et al.
Cell|April 17, 2026
Mapping intratumor heterogeneity across layers for advancing immunotherapyJean-Christophe Marine, Osnat Bartok, Shira Sagie, et al.
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Cancer Research|October 3, 2007
Serial assessment of human tumor burdens in mice by the analysis of circulating DNACarlo Rago, David L Huso, Frank Diehl, et al.
Oncotarget|October 3, 2014
The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapiesDaniel Martin, Martin C Abba, Alfredo A Molinolo, et al.
Pigment Cell & Melanoma Research|September 25, 2019
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanomaAdi Nagler, David W Vredevoogd, Michal Alon, et al.
Nature Genetics|September 1, 2009
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4Todd D Prickett, Neena S Agrawal, Xiaomu Wei, et al.
Cancer Research|December 17, 2008
Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanomaDavid A Solomon, Jung-Sik Kim, Julia C Cronin, et al.
The Journal of Investigative Dermatology|April 18, 2014
Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formationTodd D Prickett, Brad J Zerlanko, Victoria K Hill, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|June 15, 2016
Parkin Somatic Mutations Link Melanoma and Parkinson's DiseaseLotan Levin, Shani Srour, Jared Gartner, et al.
Pageof 11